Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralizing Antibodies to SARS‐CoV‐2 Selected from a Human Antibody Library Constructed Decades Ago
Min Qiang, Peixiang Ma, Yu Li, et al.
Advanced Science (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 17

Showing 17 citing articles:

Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
Pan-Pan Zhou, Ge Song, Hejun Liu, et al.
Immunity (2023) Vol. 56, Iss. 3, pp. 669-686.e7
Open Access | Times Cited: 113
Neutralizing antibodies targeting SARS-CoV-2 spike protein
Xiaojie Shi, Li Yu, Lei Yan, et al.
Stem Cell Research (2020) Vol. 50, pp. 102125-102125
Open Access | Times Cited: 109
Protective neutralizing epitopes in SARS‐CoV‐2
Hejun Liu, Ian A. Wilson
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 76-92
Open Access | Times Cited: 39
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
Siriruk Changrob, Peter Halfmann, Hejun Liu, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 8
Open Access | Times Cited: 12
Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma
Matthias M. Schneider, Marc Emmenegger, Catherine K. Xu, et al.
Life Science Alliance (2021) Vol. 5, Iss. 2, pp. e202101270-e202101270
Open Access | Times Cited: 26
Potent NTD-Targeting Neutralizing Antibodies against SARS-CoV-2 Selected from a Synthetic Immune System
Wenping Li, Fulian Wang, Yu Li, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 771-771
Open Access | Times Cited: 9
RT-PCR negative COVID-19
Heta Parmar, Margaret Montovano, Padmapriya P. Banada, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Potent Molecular Feature-based Neutralizing Monoclonal Antibodies as Promising Therapeutics Against SARS-CoV-2 Infection
Arnaud John Kombe Kombe, Ayesha Zahid, Ahmed Mohammed, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 19
Rapid Assessment of Binding Affinity of SARS-COV-2 Spike Protein to the Human Angiotensin-Converting Enzyme 2 Receptor and to Neutralizing Biomolecules Based on Computer Simulations
Damiano Buratto, Abhishek Saxena, Qun Ji, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 19
Antibody Libraries as Tools to Discover Functional Antibodies and Receptor Pleiotropism
Chih-Wei Lin, Richard A. Lerner
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 4123-4123
Open Access | Times Cited: 13
Computational approach for binding prediction of SARS-CoV-2 with neutralizing antibodies
Daria Beshnova, Yan Fang, Mingjian Du, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 2212-2222
Open Access | Times Cited: 7
Ångstrom-scale silver particles potently combat SARS-CoV-2 infection by suppressing the ACE2 expression and inflammatory responses
Yong‐Qiang Deng, Zhen‐Xing Wang, Xin Liu, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 28, pp. 5454-5464
Closed Access | Times Cited: 4
Effects of Prior Infection with SARS-CoV-2 on B Cell Receptor Repertoire Response during Vaccination
Elizabeth Fraley, Santosh Khanal, Stephen Pierce, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1477-1477
Open Access | Times Cited: 4
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct omicron SARS-CoV-2 subvariants
Siriruk Changrob, Peter Halfmann, Hejun Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Engineered Therapeutic Antibody Against SARS-CoV-2
Monrat Chulanetra
Current Clinical Microbiology Reports (2023) Vol. 10, Iss. 4, pp. 222-235
Closed Access
Site-directed neutralizing antibodies targeting structural sites on SARS-CoV-2 spike protein
Xiaofeng Li, Liudmila Kulakova, Kezzia S. Jones, et al.
New Biotechnology (2023) Vol. 80, pp. 27-36
Open Access
Page 1

Scroll to top